pET28-p53 (1-73) (72R)
(Plasmid
#62082)
-
PurposeExpression of human p53 (1-73) (72R) in e. coli
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 62082 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET28A
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5639
- Total vector size (bp) 5900
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namep53
-
Alt namep53 (1-73) (72R)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)219
-
Mutationcontains TAD residues 1-73; 72R
-
Entrez GeneTP53 (a.k.a. BCC7, BMFS5, LFS1, P53, TRP53)
- Promoter T7
-
Tag
/ Fusion Protein
- HIs (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NdeI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer T7 term (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Includes a thrombin cleavage site
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET28-p53 (1-73) (72R) was a gift from Gary Daughdrill (Addgene plasmid # 62082 ; http://n2t.net/addgene:62082 ; RRID:Addgene_62082) -
For your References section:
NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain. Vise PD, Baral B, Latos AJ, Daughdrill GW. Nucleic Acids Res. 2005 Apr 11;33(7):2061-77. Print 2005. 10.1093/nar/gki336 PubMed 15824059